At the end of 2021, Single Domain Antibody Platforms Market was valued at US$ 23.8 million; over the following ten years, it is anticipated to grow at a CAGR of 10.6%, reaching US$ 72.6 million by the end of 2032.
In 2021, the market for single domain antibodies employed by pharmaceutical and biotechnology firms was valued at US$ 9.3 Mn, or more than 39% of the whole market.
In 2021, the market for single domain antibody platforms held a 6.1% share of the worldwide custom antibody industry. Over the last six years, the market for single domain antibody platforms developed at a CAGR of 8.9%. (2015-2021).
Single domain antibody platforms are seeing revenue growth as a result of the increased incidence of immunological disorders, viral infections, and cancer as well as the rising desire for novel treatments to get better results.
Request for Free Sample Copy@ https://www.persistencemarketresearch.com/samples/28351
What Business Opportunities Await Manufacturers of Single Domain Antibody Platforms?
Rising Single Domain Antibody Use in Drug Discovery and New Cancer Therapy Development
Over the projected period, the market expansion is anticipated to be driven by quickly expanding collaborations between single domain antibody service providers and research institutes, biopharmaceutical businesses, and clinical research organisations (CROs). Market participants are working together to create new products and services as well as develop and improve critical healthcare technologies.
What’s Somewhat Limiting Demand for Single Domain Antibodies?
“Strong Regulatory Approvals, Lack of Skilled Professionals, & High Antibody Maintenance”
Regulatory restrictions will tighten as biologics move forward with commercialization and clinical studies. A Biologics License Application is required for biological product approval in the United States (BLA).
Throughout the production process, the product and the process must be validated and solely monitored against important quality attributes (CQAs).
Request For Customization@ https://www.persistencemarketresearch.com/request-customization/28351
Competitive Landscape
Leading single domain antibody platform providers are aiming at collaborations and accreditation to drive their product demand and sales footprint across countries. Single domain antibody manufacturers are focused on innovative drug development and product patenting for gaining high market revenue.
In June 2021, GenScript Biotech Corporation entered into a license agreement with Ligand Pharmaceuticals for the OmniAb® platform.
In February 2021, Kaneka Eurogentec received GMP accreditation for a new mRNA manufacturing facility for COVID-19 vaccine production.
Key Segments in Single Domain Antibody Platforms Industry Survey
Single Domain Antibody Platforms Market by Platform Type:
- Multi-specific Single-domain Antibody
- Bispecific Single-domain Antibody
- Multivalent Single-domain Antibody
- Mono-specific Single-domain Antibody
Single Domain Antibody Platforms Market by Application:
- Diagnostic Development
- Therapeutic Development
- Research & Developmental Activities
Single Domain Antibody Platforms Market by End User:
- Diagnostic Laboratories
- Clinical Laboratories
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Single Domain Antibody Platforms Market by Region:
- North America Single Domain Antibody Platforms Market
- Latin America Single Domain Antibody Platforms Market
- Europe Single Domain Antibody Platforms Market
- South Asia Single Domain Antibody Platforms Market
- East Asia Single Domain Antibody Platforms Market
- Oceania Single Domain Antibody Platforms Market
- Middle East & Africa Single Domain Antibody Platforms Market
Buy Now this Report@https://www.persistencemarketresearch.com/checkout/28351
About Us
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
Contact Us
Persistence market research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]